BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25707772)

  • 41. Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
    Hu J; Yuan IJ; Mirshahidi S; Simental A; Lee SC; Yuan X
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung cancer stem cells.
    Pine SR; Marshall B; Varticovski L
    Dis Markers; 2008; 24(4-5):257-66. PubMed ID: 18525120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment.
    Willis RE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer.
    Li GH; Huang JF
    Bioinformatics; 2014 Mar; 30(6):748-52. PubMed ID: 24162464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted Therapies in Lung Cancers: Current Landscape and Future Prospects.
    Feng X; Ding W; Ma J; Liu B; Yuan H
    Recent Pat Anticancer Drug Discov; 2021; 16(4):540-551. PubMed ID: 34132185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular matrix functions in lung cancer.
    Götte M; Kovalszky I
    Matrix Biol; 2018 Nov; 73():105-121. PubMed ID: 29499357
    [No Abstract]   [Full Text] [Related]  

  • 47. Pathogenesis of lung cancer: 100 year report.
    Miller YE
    Am J Respir Cell Mol Biol; 2005 Sep; 33(3):216-23. PubMed ID: 16107574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic similarities between organogenesis and tumorigenesis of the lung.
    Powers S; Mu D
    Cell Cycle; 2008 Jan; 7(2):200-4. PubMed ID: 18256532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular biology of lung cancer: clinical implications.
    Larsen JE; Minna JD
    Clin Chest Med; 2011 Dec; 32(4):703-40. PubMed ID: 22054881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Introduction to the Thematic Series "Targeted therapies in lung cancers"].
    Berghmans T; Mazières J
    Rev Mal Respir; 2015 Apr; 32(4):341-3. PubMed ID: 25957014
    [No Abstract]   [Full Text] [Related]  

  • 51. New molecularly targeted therapies for lung cancer.
    Sun S; Schiller JH; Spinola M; Minna JD
    J Clin Invest; 2007 Oct; 117(10):2740-50. PubMed ID: 17909619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lineage factors and differentiation states in lung cancer progression.
    Cheung WK; Nguyen DX
    Oncogene; 2015 Nov; 34(47):5771-80. PubMed ID: 25823023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung cancer and lung stem cells: strange bedfellows?
    Giangreco A; Groot KR; Janes SM
    Am J Respir Crit Care Med; 2007 Mar; 175(6):547-53. PubMed ID: 17158280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Target therapies in lung cancer.
    Bearz A; Berretta M; Lleshi A; Tirelli U
    J Biomed Biotechnol; 2011; 2011():921231. PubMed ID: 21541198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug resistance in lung cancer.
    Shanker M; Willcutts D; Roth JA; Ramesh R
    Lung Cancer (Auckl); 2010; 1():23-36. PubMed ID: 28210104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors.
    Cubero DIG; Abdalla BMZ; Schoueri J; Lopes FI; Turke KC; Guzman J; Del Giglio A; Filho CDSM; Salzano V; Fabra DG
    Drugs Context; 2018; 7():212516. PubMed ID: 30038659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mathematical Modeling Support for Lung Cancer Therapy-A Short Review.
    Smieja J
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specialized Protein Extracts: Proto-morphogenic Material has an Influential Role in Cell Signaling and Metabolic Systems.
    Troup J
    Altern Ther Health Med; 2018 Jun; 24(S1):7-9. PubMed ID: 30982006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecularly targeted chemoprevention of lung cancer.
    Gibson AD
    Clin Lung Cancer; 2003 Mar; 4(5):269-72. PubMed ID: 14609442
    [No Abstract]   [Full Text] [Related]  

  • 60. Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
    De Angelis C
    Curr Oncol; 2008 Aug; 15(4):198-9. PubMed ID: 18769606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.